EUVIMEDEUVIMED entdecken
Crossref

Development of a novel target-based cell assay, reporter of the activity of Mycobacterium tuberculosis protein- O -mannosyltransferase

Nicolas Géraud iD, Camille Falcou iD, Julien Parra iD, Carine Froment iD, David Rengel iD, Odile Burlet-Schiltz iD, Julien Marcoux iD, Jérôme Nigou iD, Michel Rivière iD, Emeline Fabre iD

Glycobiology · 30.12.2023 · 33 (12) · 1139-1154

DOI: 10.1093/glycob/cwad072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glycobiology, online erschienen am 12.09.2023. Verfasst von Nicolas Géraud und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UT3), 31400 Toulous…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: French ministry of research, Agence Nationale de la Recherche, Fondation MSDAVENIR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Protein-O-mannosyltransferase is crucial for the virulence of Mycobacterium tuberculosis, the etiological agent of tuberculosis. This enzyme, called MtPMT (Rv1002c), is responsible for the post-translational O-mannosylation of mycobacterial proteins. It catalyzes the transfer of a single mannose residue from a polyprenol phospho-mannosyl lipidic donor to the hydroxyl groups of selected Ser/Thr residues in acceptor proteins during their translocation across the membrane. Previously, we provided evidence that the loss of MtPMT activity causes the absence of mannoproteins in Mycobacterium tuberculosis, severely impacting its intracellular growth, as well as a strong attenuation of its pathogenicity in immunocompromised mice. Therefore, it is of interest to develop specific inhibitors of this enzyme to better understand mycobacterial infectious diseases. Here we report the development of a “target-based” phenotypic assay for this enzyme, assessing its O-mannosyltransferase activity in bacteria, in the non-pathogenic Mycobacterium smegmatis strain. Robustness of the quantitative contribution of this assay was evaluated by intact protein mass spectrometry, using a panel of control strains, overexpressing the MtPMT gene, carrying different key point-mutations. Then, screening of a limited library of 30 compounds rationally chosen allowed us to identify 2 compounds containing pyrrole analogous rings, as significant inhibitors of MtPMT activity, affecting neither the growth of the mycobacterium nor its secretion of mannoproteins. These molecular cores could therefore serve as scaffold for the design of new pharmaceutical agents that could improve treatment of mycobacterial diseases. We report here the implementation of a miniaturized phenotypic activity assay for a glycosyltransferase of the C superfamily.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAnimalsMiceMannosyltransferasesGlycosylationProtein Processing, Post-TranslationalMycobacterium smegmatis

Stichwörter der Autor:innen

inhibitor screeningmycobacteriaphenotypic assayprotein-O-mannosyltransferase

Substanzen

Mannosyltransferases

Autor:innen und Institutionen

  • Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UT3), 31400 Toulouse, France.
  • Infrastructure nationale de protéomique, ProFI, 205 Rte de Narbonne, 31400 Toulouse, France.

ORCID-Profile: Nicolas Géraud, Camille Falcou, Julien Parra, Carine Froment, David Rengel, Odile Burlet-Schiltz, Julien Marcoux, Jérôme Nigou, Michel Rivière, Emeline Fabre

Förderung

  • French ministry of research
  • Agence Nationale de la Recherche
  • Fondation MSDAVENIR
  • Fondation pour la Recherche Médicale

Zitieren

APA

Géraud, N., Falcou, C., Parra, J., Froment, C., Rengel, D., Burlet-Schiltz, O., Marcoux, J., Nigou, J., Rivière, M., & Fabre, E. (2023). Development of a novel target-based cell assay, reporter of the activity of Mycobacterium tuberculosis protein- O -mannosyltransferase. Glycobiology, 33(12), 1139-1154. https://doi.org/10.1093/glycob/cwad072

Vancouver

Géraud N, Falcou C, Parra J, Froment C, Rengel D, Burlet-Schiltz O, et al. Development of a novel target-based cell assay, reporter of the activity of Mycobacterium tuberculosis protein- O -mannosyltransferase. Glycobiology. 2023;33(12):1139-1154. doi:10.1093/glycob/cwad072

BibTeX
@article{Graud2023,
  author = {Géraud, Nicolas and Falcou, Camille and Parra, Julien and Froment, Carine and Rengel, David and Burlet-Schiltz, Odile and Marcoux, Julien and Nigou, Jérôme and Rivière, Michel and Fabre, Emeline},
  title = {Development of a novel target-based cell assay, reporter of the activity of Mycobacterium tuberculosis protein- O -mannosyltransferase},
  journal = {Glycobiology},
  year = {2023},
  volume = {33},
  number = {12},
  pages = {1139--1154},
  doi = {10.1093/glycob/cwad072}
}
Kostenlos starten →